Treatment of pancreatic cancer in a nude mouse model using high-intensity focused ultrasound

Jiang,Lixin; Hu,Bing; Guo,Qian; Chen,Li

doi:10.3892/etm.2012.744

Treatment of pancreatic cancer in a nude mouse model using high-intensity focused ultrasound

Authors:
- Lixin Jiang
- Bing Hu
- Qian Guo
- Li Chen
View Affiliations

Affiliations: Department of Ultrasonography, Shanghai Jiaotong University Affiliated No. 6 Hospital, Shanghai 200233, P.R. China
Published online on: October 10, 2012 https://doi.org/10.3892/etm.2012.744
Pages: 39-44

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of this study was to determine whether high-intensity focused ultrasound (HIFU) is an effective treatment for pancreatic cancer in an athymic nude mouse model. Female athymic nude mice (n=44) were inoculated subcutaneously with 5-7x106 SW1990 human pancreatic cancer cells. Thirty-six animals developed tumours and were randomly divided into three groups: HIFU (n=18), sham treatment (n=9) and control (n=9). The sonographic appearance of the tumours during therapy was recorded. After therapy, the tumours were examined transcutaneously by ultrasound every 4 days for 4 weeks. Tissue samples were taken from the treatment sites and histopathologically examined by light or electron microscopy. Two weeks after HIFU treatment, a 100% reduction in tumour volume was observed in all animals in the HIFU group, whereas tumours in the sham-treated and control groups continued to grow. Pathological examination of HIFU-treated tumour tissue samples showed complete coagulation necrosis in the tumour. Our results indicate that HIFU appears to be an effective therapy for pancreatic tumours in an athymic nude mouse model. Thus, the treatment may hold promise for the clinical treatment of late-stage and recurrent pancreatic cancer.

View Figures

View References

1	Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
2	DeVita VT, Hellman S and Rosenberg SA: Cancer: Principles and Practice of Oncology. 6th edition. Lippincott Williams & Wilkins; Philadelphia, PA: pp. 99–104. 2001
3	Gastrointestinal Tumor Study Group: Multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg. 189:205–208. 1979.
4	Whittington R, Neuberg D, Tester WJ, Benson AB III and Haller DG: Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group trial. J Clin Oncol. 13:227–232. 1995.
5	Van Leenders GJ, Beerlage HP, Ruijter ET, de la Rosette JJ and van de Kaa CA: Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol. 53:391–394. 2000.PubMed/NCBI
6	Kennedy JE: High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 5:321–327. 2005. View Article : Google Scholar : PubMed/NCBI
7	Wu F, Wang ZB, Zhu H, Zou JZ, Bai J, Li KQ, Jin CB, Xie FL and Su HB: Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology. 236:1034–1040. 2005. View Article : Google Scholar : PubMed/NCBI
8	Wang RS, Liu LX, Gu YH, Lin QF, Guo RH and Shu YQ: The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer. Biomed Pharmacother. 64:309–312. 2010. View Article : Google Scholar : PubMed/NCBI
9	Kyriazis AP, McCombs WB III, Sandberg AA, Kyriazis AA, Sloane NH and Lepera R: Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse. Cancer Res. 43:4393–4401. 1983.PubMed/NCBI
10	Keshavarzi A, Vaezy S, Noble ML, Chi EY, Walker C, Martin RW and Fujimoto VY: Treatment of uterine leiomyosarcoma in a xenograft nude mouse model using high intensity focused ultrasound: a potential treatment modality for recurrent pelvic disease. Gynecol Oncol. 86:344–350. 2002. View Article : Google Scholar
11	Wu R, Hu B, Jiang LX, Hung Y and Kuang SL: High-intensity focused ultrasound in ovarian cancer xenografts. Adv Ther. 25:810–819. 2008. View Article : Google Scholar : PubMed/NCBI
12	Vaezy S, Fujimoto VY, Walker C, Martin RW, Chi EY and Crum LA: Treatment of uterine fibroid tumours in a nude mouse model using high-intensity focused ultrasound. Am J Obstet Gynecol. 183:6–11. 2000.PubMed/NCBI
13	Khokhlova VA, Bailey MR, Reed JA, Cunitz BW, Kaczkowski PJ and Crum LA: Effects of nonlinear propagation, cavitation, and boiling in lesion formation by high intensity focused ultrasound in a gel phantom. J Acoust Soc Am. 119:1834–1848. 2006. View Article : Google Scholar : PubMed/NCBI
14	Vykhodtseva N, McDannold N, Martin H, Bronson RT and Hynynen K: Apoptosis in ultrasound produced threshold lesions in the rabbit brain. Ultrasound Med Biol. 27:111–117. 2001. View Article : Google Scholar : PubMed/NCBI
15	Leslie TA and Kennedy JE: High intensity focused ultrasound in the treatment of abdominal and gynaecological diseases. Int J Hyperthermia. 23:173–182. 2007. View Article : Google Scholar : PubMed/NCBI
16	Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Xie FL, Jin CB, Su HB and Gao GW: Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. Ultrasound Med Biol. 30:245–260. 2004. View Article : Google Scholar : PubMed/NCBI
17	Furukawa T, Kubota T, Watanabe M, Kitajima M and Hoffman RM: A novel ‘patient-like’ treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res. 53:3070–3072. 1993.